A detailed history of First Command Financial Services, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, First Command Financial Services, Inc. holds 60 shares of VRTX stock, worth $24,490. This represents 0.0% of its overall portfolio holdings.

Number of Shares
60
Previous 75 20.0%
Holding current value
$24,490
Previous $23,000 8.7%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 21, 2023

SELL
$314.42 - $351.91 $4,716 - $5,278
-15 Reduced 20.0%
60 $21,000
Q3 2022

Oct 24, 2022

SELL
$273.83 - $305.53 $6,845 - $7,638
-25 Reduced 25.0%
75 $22,000
Q3 2019

Oct 21, 2019

BUY
$166.23 - $187.09 $16,623 - $18,709
100 New
100 $17,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track First Command Financial Services, Inc. Portfolio

Follow First Command Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Command Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Command Financial Services, Inc. with notifications on news.